| [1] |
Fan S, Wang A, Wang L. Elimination of mother-to-child transmission of syphilis: challenge and solution[J]. Maternal-Fetal Med, 2019, 1(2):95-104
|
| [2] |
WHO. Report on Global Sexually Transmitted Infection Surveillance, 2018[R/OL]．(2018-12-19)[2020-10-22]．
URL
|
| [3] |
Korenromp EL, Rowley J, Alonso M, et al. Global burden of maternal and congenital syphilis and associated adverse birth outcomes-Estimates for 2016 and progress since 2012 [J]. PLoS One, 2019, 14(2):e0211720.
|
| [4] |
Gomez GB, Kamb ML, Newman LM, et al. Untreated maternal syphilis and adverse outcomes of pregnancy: a systematic review and meta-analysis [J]. Bull World Health Organ. 2013, 91(3):217-226.
|
| [5] |
Adhikari Emily H.. Syphilis in Pregnancy[J]. Obstet Gynecol, 2020，135(5):1121-1135.
|
| [6] |
樊尚荣，黎婷. 妊娠合并梅毒的诊断和处理专家共识解读 [J]. 中华产科急救电子杂志，2013, 2(2):37-41.
|
| [7] |
Qin J, Yang T, Xiao S, et al. Reported estimates of adverse pregnancy outcomes among women with and without syphilis: a systematic review and meta-analysis[J]. PLoS One, 2014, 9(7):e102203.
|
| [8] |
WHO. The global elimination of congenital syphilis: rationale and strategy for action[M/OL]. Geneva: WHO Press，2007 [2020-10-22].
URL
|
| [9] |
Tsai S, Sun MY, Kuller JA, et al. Syphilis in Pregnancy[J]. Obstet Gynecol Surv, 2019, 74(9):557-564.
|
| [10] |
Rowley J, Vander Hoorn S, Korenromp E, et al. Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016[J]. Bull World Health Organ, 2019, 97(8):548-562.
|
| [11] |
WHO. WHO guidelines for the treatment of Treponema pallidum (syphilis)[M/OL]. Geneva: WHO Press，2016 [2020-10-22].
URL
|
| [12] |
WHO. Investment case for eliminating mother-to-child transmission of syphilis: promoting better maternal and child health and stronger Health systems[M/OL]. Geneva: WHO Press，2012 [2020-10-22]．
URL
|
| [13] |
邓宝清，晏瑞琳，黄志明，等. 深圳市宝安区妊娠梅毒患者性伴梅毒感染情况及影响因素分析[J]．中国皮肤性病杂志，2019，33(4):442-446.
|
| [14] |
邱莉霞，胡瑞娟，许宗严，等. 深圳市福田区2005-2011年妊娠梅毒患者流行病学分析[J]. 实用预防医学，2012，19(8):1215-1217.
|
| [15] |
Zhang XH, Xu J, Chen DQ, et al. Effectiveness of treatment to improve pregnancy outcomes among women with syphilis in Zhejiang Province, China[J]. Sex Transm Infect, 2016, 92(7):537-541.
|
| [16] |
Zhang X, Yu Y, Yang H, et al. Surveillance of Maternal Syphilis in China: Pregnancy Outcomes and Determinants of Congenital Syphilis [J]. Med Sci Monit, 2018, 24:7727-7735.
|
| [17] |
Li HX, Tan JJ, Luo ZW, et al. Standardized treatment and determinants on 9，059 syphilis？infected pregnant women during 2015-2018 in Hunan, China[J]. Sci Rep, 2020, 10(1):12026.
|
| [18] |
Dou L, Wang X, Wang F, et al. Epidemic profile of maternal syphilis in China in 2013[J]. Biomed Res Int, 2016:9194805.
|
| [19] |
Su JR, Brooks LC, Davis DW, et al. Congenital syphilis: trends in mortality and morbidity in the United States, 1999 through 2013[J]. Am J Obstet Gynecol, 2016, 214(3):381.e1-e9.
|
| [20] |
Kidd S, Bowen VB, Torrone EA, et al. Use of national syphilis surveillance data to develop a congenital syphilis prevention cascadeand estimate the number of potential congenital syphilis cases averted[J]. Sex Transm Dis, 2018, 45(9S Suppl 1):S23-S28.
|
| [21] |
Trinh T, Leal AF, Mello MB, et al. Syphilis Management in Pregnancy: A Review of Guideline Recommendations From Countries Around the World [J]. Sex Reprod Health Matters. 2019, 27(1):69-82.
|
| [22] |
Cavalcante PAM, Pereira RBL, Castro JGD. Syphilis in pregnancy and congenital syphilis in Palmas, Tocantins State, Brazil, 2007-2014 [J]. Epidemiol Serv Saude, 2017, 26(2):255-264.
|
| [23] |
Enkhbat E, Korenromp EL, Badrakh J, et al. Adult female syphilis prevalence, congenital syphilis case incidence and adverse birth outcomes, Mongolia 2000-2016: Estimates using the Spectrum STI tool [J]. Infect Dis Model, 2018, 3:13-22.
|
| [24] |
Silva Neto SED, Silva SSBED, Sartori AMC. Syphilis in pregnancy, congenital syphilis, and factors associated with mother-to-child transmission in Itapeva, S？o Paulo, 2010 to 2014[J]. Rev Soc Bras Med Trop, 2018, 51(6):819-826.
|
| [25] |
Kuznik A, Habib AG, Manabe YC, et al. Estimating the public health burden associated with adverse pregnancy outcomes resulting from syphilis infection across 43 countries in Sub-Saharan Africa[J]. Sex Transm Dis, 2015, 42(7):369-375.
|
| [26] |
WHO. WHO Guideline on Syphilis Screening and Treatment for Pregnant Women [M/OL]. Geneva: WHO Press，2017 [2020-10-22]．
URL
|
| [27] |
樊尚荣；中华医学会妇产科学分会感染性疾病协作组．妊娠合并梅毒诊断和治疗专家共识[J]. 中华妇产科杂志，2012，39(6):430-431.
|
| [28] |
Workowski KA, Bolan GA. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015[J]. MMWR Recomm Rep，2015, 64(RR-03):1-137.
|
| [29] |
Clement ME, Okeke NL, Hicks CB, et al. Treatment of syphilis: a systematic review[J]. JAMA, 2014, 312(18):1905-1917.
|
| [30] |
Hong FC, Wu XB, Yang F, et al. Risk of congenital syphilis (CS) following treatment of maternal syphilis: results of a CS control program in China[J]. Clin Infect Dis, 2017, 65(4):588-594.
|
| [31] |
Liu H, Chen N, Yu J, et al. Syphilis-attributable adverse pregnancy outcomes in China: a retrospective cohort analysis of 1187 pregnant women with different syphilis treatment[J]. BMC Infect Dis, 2019, 19(1):292.
|
| [32] |
Rac MW, Bryant SN, McIntire DD, et al. Progression of ultrasound findings of fetal syphilis after maternal treatment[J]. Am J Obstet Gynecol, 2014, 211(4):426.e1-e6.
|
| [33] |
Wu Z, Zhou P. Syphilis and social upheaval in China[J]. N Engl J Med, 2010, 363(11):1088.
|
| [34] |
Ye X, Tang SK, Dai X, et al. Over reporting of congenital syphilis in Guangzhou, China[J]. Sex Health, 2015, 12(2):174-175.
|
| [35] |
Janier M, Hegyi V, Dupin N, et al. 2014 European guideline on the management of syphilis[J]. J Eur Acad Dermatol Venereol, 2014, 28(12): 1581-1593.
|
| [36] |
Torres RG, Mendon？a ALN, Montes GC, et al. Syphilis in pregnancy: the reality in a public hospital[J]. Rev Bras Ginecol Obstet, 2019, 41(2):90-96.
|
| [37] |
Gliddon HD, Peeling RW, Kamb ML, et al. A systematic review and meta-analysis of studies evaluating the performance and operational characteristics of dual point-of-care tests for HIV and syphilis[J]. Sex Transm Infect, 2017, 93(S4):S3-S15.
|
| [38] |
WHO. Global Guidance on Criteria and Processes for Validation: Elimination of Mother-to-child Transmission (EMTCT) of HIV and Syphilis[M/OL]. Geneva: WHO Press，2014 [2020-10-22].
URL
|
| [39] |
WHO. Global guidance on criteria and processes for validation: elimination of Mother-to-child Transmission of HIV and Syphilis, 2nd edition[M/OL]. Geneva: WHO Press，2017 [2020-10-22].
URL
|